Matching articles for "additional note"
Issue 1052 · May 7, 1999 Free
Lyme Disease Vaccine: An Additional Note

Some readers have asked why the Medical Letter article on Lyme Disease Vaccine (Vol 41, p. 29) concluded that its long-term safety is worrisome....

Med Lett Drugs Ther. 1999 May 7; 41(1052):46
Some readers have asked why the Medical Letter article on Lyme Disease Vaccine (Vol 41, p. 29) concluded that its long-term safety is worrisome....
Issue 976 · June 7, 1996
The Prostatron: Microwaves for Benign Prostatic Hyperplasia

The Prostatron, a microwave device manufactured by EDAP Technomed in Cambridge, MA, has been approved by the US Food and Drug Administration for treating symptoms of benign prostatic hyperplasia (BPH).

Med Lett Drugs Ther. 1996 Jun 7; 38(976):53-4
The Prostatron, a microwave device manufactured by EDAP Technomed in Cambridge, MA, has been approved by the US Food and Drug Administration for treating symptoms of benign prostatic hyperplasia (BPH).
Issue 958 · September 29, 1995
Mycophenolate Mofetil - A New Immunosuppressant for Organ Transplantation

Mycophenolate mofetil ( CellCept - Roche) has been approved by the US Food and Drug Administration for oral use in preventing organ rejection in patients receiving allogeneic renal transplants. It is being…

Med Lett Drugs Ther. 1995 Sep 29; 37(958):84-6
Mycophenolate mofetil ( CellCept - Roche) has been approved by the US Food and Drug Administration for oral use in preventing organ rejection in patients receiving allogeneic renal transplants. It is being promoted as an improvement over azathioprine (Imuran) for concurrent use with cyclosporine (Sandimmune; Neoral) and corticosteroids.
Issue 797 · July 28, 1989
Measles Revaccination

In the first six months of 1989, more than 7,000 cases of measles were reported to the US Centers for Disease Control (CDC), a sharp increase over previous years (Morbid Mortal Weekly Rep, 33:456, July 7,…

Med Lett Drugs Ther. 1989 Jul 28; 31(797):69-70
In the first six months of 1989, more than 7,000 cases of measles were reported to the US Centers for Disease Control (CDC), a sharp increase over previous years (Morbid Mortal Weekly Rep, 33:456, July 7, 1989). Many of these cases occurred in children and college students who had previously been vaccinated against the disease. Practitioners have asked, therefore, whether their previously immunized young patients should receive a second (or, in some cases, third) immunization against measles.
Issue 781 · December 16, 1988
Drugs for Parkinsonism

Patients with Parkinson's disease have a deficiency of the neurotransmitter dopamine, a catecholamine. Dpamine itself cannot be used to treat the disease because it does not cross the blood-brain barrier, but…

Med Lett Drugs Ther. 1988 Dec 16; 30(781):113-6
Patients with Parkinson's disease have a deficiency of the neurotransmitter dopamine, a catecholamine. Dpamine itself cannot be used to treat the disease because it does not cross the blood-brain barrier, but its metabolic precursor, levodopa, does cross into the brain and is converted to dopamine by a decarboxylase present both in the brain and in the intestinal tract (JM Cedarbaum, Clin Pharmacokinet, 13:141, 1987).
Issue 781 · December 16, 1988
Acesulfame - A New Artificial Sweeteners

Acesulfame potassium ( Sunette - Hoechst), an oxathiazinondioxide, was recently approved by the US Food and Drug Administration (FDA) for use as a non-caloric table-top sweetener and as an ingredient in…

Med Lett Drugs Ther. 1988 Dec 16; 30(781):116
Acesulfame potassium ( Sunette - Hoechst), an oxathiazinondioxide, was recently approved by the US Food and Drug Administration (FDA) for use as a non-caloric table-top sweetener and as an ingredient in chewing gum, powdered beverages, gelatins and puddings. The other non-caloric artificial sweeteners available in the USA are saccharin ( Sweet 'N Low ; and others) and aspartame ( NutraSweet ; Equal) (Medical Letter, 24:1, 1982).